INTERNATIONAL PATENT: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. FILES APPLICATION FOR "THERAPEUTIC OLIGONUCLEOTIDES FOR TREATING DISEASES BEING ASSOCIATED WITH OR CAUSED BY A MISSENSE, NONSENSE OR IN-FRAME INDEL MUTATION"

GENEVA, Dec. 31 -- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (HofgartenstraBe 880539 Munchen) filed a patent application (PCT/EP2025/067207) for "THERAPEUTIC OLIGONUCLEOTIDES FOR TREATING DISEASES BEING ASSOCIATED WITH OR CAUSED BY A MISSENSE, NONSENSE OR IN-FRAME INDEL MUTATION" on Jun 18, 2025. With publication no. WO/2025/262186, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FALCUCCI, Lara (c/o Max Planck Institute for Heart and Lung Research61231 Bad Nauheim), DOOLEY, Christopher (c/o Max Planck ...